Lotus Pharmaceutical reports Aug revenue of NT$2.11B vs NT$1.16B
Lotus Pharmaceutical Co. Ltd. reported 2026 revenue of NT$2,107,202,000 versus NT$1,159,844,000 in 2025. It also reported Jan–Aug revenue of NT$22,051,986,000 versus NT$13,033,975,000.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.